February 21, 2021 / Insights
Despite different underlying pathogenic processes, inflammation is a common denominator in DED, which in turn induces further damage to the corneal epithelium and its underlying structures. Various treatment modalities, such as steroids and cyclosporine, have been used to suppress inflammation. However, results are variable and refractory in some cases. In these cases, DED not only negatively impacts the quality of life, but also increases the burden on health economics.
Share This Article